TILMELD DIG NYHEDSBREVET
Seneste erhvervsnyt fra borgmesterenFå alle events og inspirerende historier direkte i din indbakke
Nyhedsbrevet Seneste erhvervsnyt fra borgmesteren udkommer løbende over året og indeholder både de gode historier fra byens erhvervsliv og invitationer til erhvervsrettede events.
Ønsker du at afmelde dig igen, vil du nemt kunne gøre det i bunden af hvert nyhedbrev, som du modtager. Læs i øvrigt mere i vores generelle terms.
Vi glæder os til at dele alle de gode historier med dig.
Tilmeld dig nyhedsbrevet i formularen herunder
Seneste artikler om Odenses erhvervsliv
Odense takes the lead: 14 Million DKK to Boost Competencies in the Life Science Sector
With a fresh injection of 14 million DKK UCL University College is set to transform Denmark’s life science sector by placing Odense firmly on the map as the nation’s innovation powerhouse. As the coordinating hub for a nationwide upskilling initiative, Odense is sending a clear signal to international investors: this is where the future of life science is being shaped.
Global investment meets Odense innovation – Evosep enters a new era in clinical proteomics
With Nordic Capital as majority shareholder, Evosep strengthens its global position – and Odense’s role as a rising life science city. The recent acquisition of Evosep by Nordic Capital marks the biggest direct life science exit in EIFO history. It’s a clear signal that Denmark is not just participating in the global health innovation race – we’re building companies that can lead it.
Inverna Therapeutics Receives Major Grant from the Michael J. Fox Foundation to Boost Parkinson’s Research
Inverna Therapeutics has been awarded a USD 700,000 research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), one of the world’s leading supporters of Parkinson’s innovation. The funding will help advance Inverna’s next-generation RNA therapy, a new approach aimed at slowing or stopping the progression of Parkinson.